Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Galecto Inc
GLTO | US
26.71
USD1.11
4.34%
GLTO | US
About Galecto Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/04/2026
Close
26.71
Open
24.96
High
26.99
Low
24.95
Galecto Inc. a clinical-stage biotechnology company develops molecules for the treatment of fibrosis cancer inflammation and other related diseases. The company's lead product candidate is GB2064 which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139 an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases such as idiopathic pulmonary fibrosis a life-threatening progressive fibrotic disease of the lung; GB2064 a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211 a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer as well as in Phase Ib/IIa for fibrosis. Galecto Inc. was founded in 2011 and is headquartered in Copenhagen Denmark.
View LessGLTO | US
Risk
163.2
Sharpe
1.93
Luna's Score
63/100
Recommendation
Hold
Luna says (GLTO | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
65.6%1 month
163.2%3 months
133.8%6 months
402.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.37
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
0.46
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-21.91M
MarketCap
35.01M
MarketCap(USD)
35.01M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-75.57
Short ratio
0.27
Short perc.
1.23
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
4.76
Range1M
12.72
Range3M
17.49
Volumes: Market Activity
Rel. volume
1.06
Price X volume
9.01M
